Stanford Cancer Institute

Latest articles

18h
New America Media
NAM Honors 'Ethnic Media Champions' at 2017 Awards Celebrationceremonies were Odette Alcazaren-Keeley of New America Media and Martin Reynold
New America Media / Posted 18 hours ago
ceremonies were Odette Alcazaren-Keeley of New America Media and Martin Reynolds, co-executive director of the Maynard institute for Journalism Education. Odette Alcazaren-Keeley of New America Media and Maynard Inst. for Journalism Education... Read more
1d
San Francisco Chronicle
Sean Parker institute to lead immunotherapy trial for pancreatic cancerThe Parker Institute for Cancer Immunotherapy, the San Francisco nonprofit cre
San Francisco Chronicle / Posted yesterday
The Parker Institute for Cancer Immunotherapy, the San Francisco nonprofit created in 2016 with $250 million from the billionaire former Facebook executive who helped build Napster, will sponsor its first clinical trial — an immunotherapy treatment... Read more
1d
San Antonio Express-News
Sean Parker institute to lead immunotherapy trial for pancreatic cancerThe Parker Institute for Cancer Immunotherapy, the San Francisco nonprofit cre
San Antonio Express-News / Posted yesterday
The Parker Institute for Cancer Immunotherapy, the San Francisco nonprofit created in 2016 with $250 million from the billionaire former Facebook executive who helped build Napster, will sponsor its first clinical trial — an immunotherapy treatment... Read more
3d
The Hill
How we measure poverty is key to knowing who is poorpoverty. Maybe that’s why the poverty rate in 2016 is basically identical to 2
The Hill / Posted 3 days ago
poverty. Maybe that’s why the poverty rate in 2016 is basically identical to 2006, 1996 and so on. The government could institute a program to guarantee every American a basic income — a concept I believe holds great merit — but the poverty rate... Read more
6d
Swissinfo
Rich People From These Nations Hide the Most Offshore Wealth (Correct)1970. That’s happening as research productivity is declining at a rate that ave
Swissinfo / Posted 6 days ago
1970. That’s happening as research productivity is declining at a rate that averages 6.8 percent per year, new research by Stanford University economist Nicholas Bloom and co-authors finds. Likewise, research productivity for agricultural seed... Read more
8d
The Mercury News
Stanford study: Three-quarters of opioid prescriptions written for 10 percent of patientsA new Stanford study reveals a startling fact about the nation’s opioid crisis:
The Mercury News / Posted 8 days ago
A new Stanford study reveals a startling fact about the nation’s opioid crisis: A small minority of Americans account for the large majority of drug abusers. Opioids aren’t widely overused by the general population, as often presumed. Rather, more... Read more
9d
Newsweek
The male infertility crisis: Who's killing America's sperm?evidence that that function of reproduction is failing,” says Michael Eisenberg
Newsweek / Posted 9 days ago
evidence that that function of reproduction is failing,” says Michael Eisenberg, a urologist and an associate professor at Stanford University, referring to the latest sperm-level research. “We should try to figure out why that is.” What we do... Read more
9d
Swissinfo
Rich People From These Nations Hide the Most Offshore Wealth1970. That’s happening as research productivity is declining at a rate that ave
Swissinfo / Posted 9 days ago
1970. That’s happening as research productivity is declining at a rate that averages 6.8 percent per year, new research by Stanford University economist Nicholas Bloom and co-authors finds. Likewise, research productivity for agricultural seed... Read more
9d
The Register
Boffins fear we might be running out of ideasthe semiconductor industry. In other words, we're running out of ideas. That's
The Register / Posted 9 days ago
the semiconductor industry. In other words, we're running out of ideas. That's the conclusion of economic researchers from Stanford University and the Massachusetts Institute of Technology. In a paper published Monday through the National Bureau... Read more
11d
Business Wire
Pfizer Presents Positive Pivotal Data for PF-05280014, an Investigational Biosimilar to Herceptin® (trastuzumab), at the European Society for Medical Oncology (ESMO) 2017 Congressaccess to high quality and effective therapies,” said Dr. Mark Pegram, associat
Business Wire / Posted 11 days ago
access to high quality and effective therapies,” said Dr. Mark Pegram, associate director for clinical research at the Stanford Comprehensive Cancer Institute, and director of the Breast Oncology Program at the Stanford Women’s Cancer Center.... Read more
12d
Hindustantimes.com
Why India’s most educated women are leaving jobs faster than othersthat Mittal wrote her first book, Heartbreaks & Dreams: The Girls@IIT. With a
Hindustantimes.com / Posted 12 days ago
that Mittal wrote her first book, Heartbreaks & Dreams: The Girls@IIT. With a degree in electrical engineering from Indian Institute of Technology, Delhi, and a Masters in Computer Science from the University of Michigan (Ann Arbor), Mittal had... Read more
13d
Philly.com
More doctors are practicing past age 70. Is that safe for patients?and cognitive changes that could imperil patients. So, in June, Sharrar underw
Philly.com / Posted 13 days ago
and cognitive changes that could imperil patients. So, in June, Sharrar underwent hours of testing at Rowan University’s Institute for Successful Aging to measure whether he was strong enough to do his job — could he lift a 20-pound child? — and... Read more
22d
Northwest Herald
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Northwest Herald / Posted 22 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
23d
Business Wire
PureTech Health Exclusively Licenses Glyph Technology from Monash University to Harness Lymphatic Biologyplatform (the Glyph technology) based on the pioneering research of Christopher
Business Wire / Posted 23 days ago
platform (the Glyph technology) based on the pioneering research of Christopher Porter, Ph.D., Director of the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University in Australia. The Glyph technology is aimed at harnessing... Read more
23d
Athens Banner-Herald
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Athens Banner-Herald / Posted 23 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
Gulf News
A first: Drug lowers heart risks by curbing inflammationPeople on the drug also had surprisingly lower cancer death rates Washington:
Gulf News / Posted 24 days ago
People on the drug also had surprisingly lower cancer death rates Washington: For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and different approach than lowering cholesterol, the focus for many... Read more
103 related articles
24d
KFVS 12 Cape Girardeau
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
KFVS 12 Cape Girardeau / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
The Columbian
Drug curbs heart inflammation, may prevent future attacksdifferent approach than lowering cholesterol, the focus for many years. People
The Columbian / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
Savannah Morning News
In first, drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Savannah Morning News / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
KSLA-TV Shreveport
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
KSLA-TV Shreveport / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
TribLIVE
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
TribLIVE / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
Chattanooga Times Free Press
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Chattanooga Times Free Press / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
KELO Sioux Falls
A First: Drug Lowers Heart Risks By Curbing Inflammationdifferent approach than lowering cholesterol, the focus for many years. People
KELO Sioux Falls / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
The News-Herald
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
The News-Herald / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
WFMJ Youngstown
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
WFMJ Youngstown / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
24d
Newsmax
A First: Drug Lowers Heart Risks by Curbing Inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Newsmax / Posted 24 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
Savannah Morning News
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Savannah Morning News / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
WXOW 19 La Crosse
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
WXOW 19 La Crosse / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
FOX 6 Milwaukee
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
FOX 6 Milwaukee / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
The Middletown Press
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
The Middletown Press / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
WFLX FOX 29
Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
WFLX FOX 29 / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
New York Post
New drug fights against heart attacks and cancerdifferent approach than lowering cholesterol, the focus for many years. People
New York Post / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
CTV News
A first: Drug lowers heart attack risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
CTV News / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumour effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
WFMZ Eastern Pennsylvania and Western New Jersey
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
WFMZ Eastern Pennsylvania and Western New Jersey / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
Hawaii News Now
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Hawaii News Now / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
WECT 6 Wilmington
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
WECT 6 Wilmington / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
Arizona Daily Sun
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Arizona Daily Sun / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
WLOX-TV Biloxi
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
WLOX-TV Biloxi / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
The Chippewa Herald
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
The Chippewa Herald / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
Chattanooga Times Free Press
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Chattanooga Times Free Press / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
The Greater New Milford Spectrum
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
The Greater New Milford Spectrum / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
The Hamilton Journal News
A first: Drug lowers heart risks by curbing inflammationNovartis, sponsored the study. (Georgios Kefalas/Keystone via AP, File) People
The Hamilton Journal News / Posted 25 days ago
Novartis, sponsored the study. (Georgios Kefalas/Keystone via AP, File) People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
WSOC-TV Charlotte
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
WSOC-TV Charlotte / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
The New Canaan News
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
The New Canaan News / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
Missoulian
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Missoulian / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
Connecticut Post
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Connecticut Post / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
The Times and Democrat
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
The Times and Democrat / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
Lincoln Journal Star
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Lincoln Journal Star / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
WFTV 9 Orlando
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
WFTV 9 Orlando / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
25d
Santa Maria Times
A first: Drug lowers heart risks by curbing inflammationdifferent approach than lowering cholesterol, the focus for many years. People
Santa Maria Times / Posted 25 days ago
different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more... Read more
103 related articles
More

In this news